FindTrial
Sign In

moxifloxacin hydrochloride

DRUG10 trials

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC, OHSU Knight Cancer Institute, Bp Consulting, Inc, Bausch & Lomb Incorporated, Vertex Pharmaceuticals Incorporated

Conditions

Anesthesia; Adverse EffectBreast CancerCOPD Exacerbation AcuteCardiac ArrhythmiaCataract ExtractionCataractsChronic Myeloproliferative DisordersCystic Fibrosis

Phase 1

Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects
CompletedNCT00824070
Bausch & Lomb IncorporatedCataract Extraction
Start: 2009-02-28End: 2009-08-31Updated: 2011-12-13
Phase 1, QT/QTC Interval Study in Healthy Subjects
CompletedNCT01910415
Vertex Pharmaceuticals IncorporatedCystic Fibrosis
Start: 2013-06-30End: 2014-03-31Updated: 2014-08-11
Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval
CompletedNCT04821063
ItalfarmacoDuchenne and Becker Muscular Dystrophy, Polycytemia Vera
Start: 2021-04-13End: 2021-06-18Updated: 2024-01-11
Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval
NCT04898907
Angion Biomedica CorpHealthy Volunteer
Start: 2021-06-30End: 2021-09-30Target: 48Updated: 2021-06-01
Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects
NCT05660720
Beijing InnoCare Pharma Tech Co., Ltd.Healthy Subject
Start: 2022-11-19End: 2023-08-31Target: 48Updated: 2022-12-21
Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)
CompletedNCT06795204
Haisco-USA Pharmaceuticals, Inc.Anesthesia; Adverse Effect, Cardiac Arrhythmia
Start: 2024-04-09End: 2024-11-26Updated: 2026-01-13

Phase 3

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
TerminatedNCT00324324
OHSU Knight Cancer InstituteBreast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor +9
Start: 2006-05-31End: 2012-12-31Target: 240Updated: 2017-05-09

Phase 4

Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery
CompletedNCT00758199
Bp Consulting, IncCataracts
Start: 2008-07-31End: 2010-01-31Updated: 2012-03-15
A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
CompletedNCT05400369
Daiichi SankyoCOPD Exacerbation Acute
Start: 2022-08-10End: 2024-09-25Updated: 2025-01-09

Unknown Phase

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
TerminatedNCT00062231
European Organisation for Research and Treatment of Cancer - EORTCChronic Myeloproliferative Disorders, Fever, Sweats, and Hot Flashes, Infection +8
Start: 2002-04-30Updated: 2012-09-24